Статья
Фармакоинвазивный подход к лечению острого инфаркта миокарда с подъемом сегмента ST
В статье представлены основные данные о фармакоинвазивном подходе при остром инфаркте миокарда с подъемом сегмента ST. Современные рекомендации отдают предпочтение первичному чрескожному коронарному вмешательству, однако как в Российской Федерации, так и за рубежом есть ряд особенностей (логистические проблемы, особенности оснащения медицинских учреждений), которые нередко препятствуют возможности своевременного выполнения эндоваскулярного лечения. В таких случаях тромболитическая терапия, впоследствии дополненная чрескожным коронарным вмешательством, может оказаться наиболее эффективной стратегией, цель которой – максимально раннее восстановление коронарной перфузии. В статье рассмотрены результаты основных исследований такого подхода, а также данные о применении тромболитической терапии отечественным препаратом третьего поколения рекомбинантная проурокиназа.
1. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology. 2013;61(4):e78–140. DOI: 10.1016/j.jacc.2012.11.019
2. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119– 77. DOI: 10.1093/eurheartj/ehx393
3. Здравоохранение в России. 2017. Статистический сборник. – M.: Росстат, 2017. – 170с. Доступно на: http://www.gks.ru/free_doc/doc_2017/zdrav17.pdf. ISBN 978-5-89476-448-1
4. Эрлих А.Д. Как за последние несколько лет изменилось лечение пациентов с острым коронарным синдромом с подъемом сегмента ST в клинической практике (данные серии российских регистров “РЕКОРД”). Кардиология. 2018;58(7):23-31. DOI: 10.18087/cardio.2018.7.10140
5. Попонина Т.М., Попонина Ю.С., Васильев А.Г. Риск и выгода реперфузионных стратегий в лечении больных острым инфарктом миокарда с подъемом сегмента ST. Российский кардиологический журнал. 2010;15(5):103-15
6. Armstrong PW, Van de Werf F. No STEMI left behind. The Journal of the Association of Physicians of India. 2014;62(6):469–70. PMID: 25856910
7. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction: A Meta-analysis. JAMA. 2000;283(20):2686–92. DOI: 10.1001/jama.283.20.2686
8. Johanson P, Fu Y, Wagner GS, Goodman SG, Granger CB, Wallentin L et al. ST Resolution 1 Hour After Fibrinolysis for Prediction of Myocardial Infarct Size: Insights from ASSENT 3. The American Journal of Cardiology. 2009;103(2):154–8. DOI: 10.1016/j.amjcard.2008.08.054
9. Sinnaeve PR, Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Lambert Y et al. ST–Segment-Elevation Myocardial Infarction Patients Randomized to a Pharmaco-Invasive Strategy or Primary Percutaneous Coronary Intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-Year Mortality Follow-Up. Circulation. 2014;130(14):1139–45. DOI: 10.1161/CIRCULATIONAHA.114.009570
10. Bonnefoy E, Steg PG, Boutitie F, Dubien P-Y, Lapostolle F, Roncalli J et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. European Heart Journal. 2009;30(13):1598–606. DOI: 10.1093/eurheartj/ehp156
11. Westerhout CM, Bonnefoy E, Welsh RC, Steg PG, Boutitie F, Armstrong PW. The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST. American Heart Journal. 2011;161(2):283–90. DOI: 10.1016/j.ahj.2010.10.033
12. Perez de Arenaza D, Taneja AK, Flather M. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction (PRAGUE-2 trial). European Heart Journal. 2003;24(19):1798. DOI: 10.1016/j.ehj.2003.06.001
13. Widimský P. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction Final results of the randomized national multicentre trial—PRAGUE-2. European Heart Journal. 2003;24(1):94–104. DOI: 10.1016/S0195-668X(02)00468-2
14. Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, Vázquez N, Blanco J, Alonso-Briales J et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. The Lancet. 2004;364(9439):1045–53. DOI: 10.1016/S0140-6736(04)17059-1
15. Fernandez-Avilés F, Alonso JJ, Castro-Beiras A. Routine invasive strategy within 24 hours of thrombolysis versus ischemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): A randomized controlled trial. ACC Current Journal Review. 2004;13(12):35. DOI: 10.1016/j.accreview.2004.11.044
16. Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D et al. Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study). Journal of the American College of Cardiology. 2005;46(3):417–24. DOI: 10.1016/j.jacc.2005.04.042
17. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. Journal of the American College of Cardiology. 2003;42(4):634–41. DOI: 10.1016/S0735-1097(03)00763-0
18. ernandez-Aviles F, Alonso JJ, Pena G, Blanco J, Alonso-Briales J, Lopez-Mesa J et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. European Heart Journal. 2007;28(8):949–60. DOI: 10.1093/eurheartj/ehl461
19. Janssens L, Heart Centre, Department of Cardiology, Imeldahospital, 2820 Bonheiden, Belgium. E: luc.janssens.cardio@telenet.be. Early Treatment of ST-segment-elevation Myocardial Infarction Incorporating Results of the FINESSE Trial. European Cardiology Review. 2009;5(1):85–90. DOI: 10.15420/ECR.2009.5.1.85
20. Di Mario C, Bolognese L, Maillard L, Dudek D, Gambarati G, Manari A et al. Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI). American Heart Journal. 2004;148(3):378–85. DOI: 10.1016/j.ahj.2004.03.038
21. Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena E et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. The Lancet. 2008;371(9612):559–68. DOI: 10.1016/S0140-6736(08)60268-8
22. Bøhmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). Journal of the American College of Cardiology. 2010;55(2):102–10. DOI: 10.1016/j.jacc.2009.08.007
23. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA et al. Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction. New England Journal of Medicine. 2009;360(26):2705–18. DOI: 10.1056/NEJMoa0808276
24. Arbel Y, Ko DT, Yan AT, Cantor WJ, Bagai A, Koh M et al. Longterm Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). Canadian Journal of Cardiology. 2018;34(6):736–43. DOI: 10.1016/j.cjca.2018.02.005
25. Shiomi H, Morimoto T, Kitaguchi S, Nakagawa Y, Ishii K, Haruna Y et al. The ReACT Trial: Randomized Evaluation of Routine Followup Coronary Angiography After Percutaneous Coronary Intervention Trial. JACC: Cardiovascular Interventions. 2017;10(2):109–17. DOI: 10.1016/j.jcin.2016.10.018
26. Danchin N, Blanchard D, Steg PG, Sauval P, Hanania G, Goldstein P et al. Impact of Prehospital Thrombolysis for Acute Myocardial Infarction on 1-Year Outcome: Results From the French Nationwide USIC 2000 Registry. Circulation. 2004;110(14):1909–15. DOI: 10.1161/01.CIR.0000143144.82338.36
27. Hanssen M, Cottin Y, Khalife K, Hammer L, Goldstein P, Puymirat E et al. French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010. Heart. 2012;98(9):699– 705. DOI: 10.1136/heartjnl-2012-301700
28. Sinnaeve PR, Van de Werf F. Primary Percutaneous Coronary Intervention Not Always the Best Reperfusion Strategy? Circulation. 2014;129(16):1623–5. DOI: 10.1161/CIRCULATIONAHA.114.009226
29. Rodriguez-Granillo GA, Rodriguez AE, Milei J. Letter by RodriguezGranillo et al Regarding Article, “Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015”. Circulation. 2018;137(21):2305–6. DOI: 10.1161/CIRCULATIONAHA.117.033093
30. Helal AM, Shaheen SM, Elhammady WA, Ahmed MI, Abdel-Hakim AS, Allam LE. Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction. IJC Heart & Vasculature. 2018;21:87–93. DOI: 10.1016/j.ijcha.2018.10.006
31. Stenestrand U, Lindbäck J, Wallentin L, RIKS-HIA Registry for the. Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With ST-Elevation Myocardial Infarction. JAMA. 2006;296(14):1749–56. DOI: 10.1001/jama.296.14.1749
32. French WJ, Reddy VS, Barron HV. Transforming Quality of Care and Improving Outcomes After Acute MI: Lessons From the National Registry of Myocardial Infarction. JAMA. 2012;308(8):771. DOI: 10.1001/jama.2012.9500
33. Khan JN, Razvi N, Nazir SA, Singh A, Masca NG, Gershlick AH et al. Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction. Journal of Cardiovascular Magnetic Resonance. 2014;16(1):38. DOI: 10.1186/1532-429X-16-38
34. Sim DS, Jeong MH, Ahn Y, Kim YJ, Chae SC, Hong TJ et al. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction: A Propensity Score–Matched Analysis. Circulation: Cardiovascular Interventions. 2016;9(9):e003508. DOI: 10.1161/CIRCINTERVENTIONS.115.003508
35. Rashid MK, Guron N, Bernick J, Wells GA, Blondeau M, Chong A-Y et al. Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System. JACC: Cardiovascular Interventions. 2016;9(19):2014–20. DOI: 10.1016/j.jcin.2016.07.004
36. Bodí V, Rumiz E, Merlos P, Nunez J, López-Lereu MP, Monmeneu JV et al. One-Week and 6-Month Cardiovascular Magnetic Resonance Outcome of the Pharmacoinvasive Strategy and Primary Angioplasty for the Reperfusion of ST-Segment Elevation Myocardial Infarction. Revista Española de Cardiología. 2011;64(2):111–20. DOI: 10.1016/j.recesp.2010.10.008
37. Садыков Т.Т., Самко А.Н., Староверов И.И. Госпитальные результаты фармакоинвазивного подхода у больных острым инфарктом миокарда с подъемом сегмента ST. Атеросклероз и дислипидемии. 2014;2(15):23-32
38. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394